Handelsbanken Fonder’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5M Buy
405,000
+157,700
+64% +$11.3M 0.1% 174
2026
Q1
$16.3M Buy
247,300
+41,500
+20% +$2.64M 0.05% 270
2025
Q4
$13.1M Sell
205,800
-28,700
-12% -$1.79M 0.04% 346
2025
Q3
$12.9M Buy
234,500
+202,200
+626% +$8.33M 0.04% 338
2025
Q2
$1.07M Hold
32,300
﹤0.01% 931
2025
Q1
$1.3M Hold
32,300
0.01% 834
2024
Q4
$1.52M Buy
32,300
+2,900
+10% +$151K 0.01% 784
2024
Q3
$1.55M Buy
29,400
+5,900
+25% +$329K 0.01% 752
2024
Q2
$1.27M Buy
23,500
+800
+4% +$48.3K 0.01% 735
2024
Q1
$1.59M Buy
22,700
+2,900
+15% +$224K 0.01% 671
2023
Q4
$1.65M Buy
19,800
+2,400
+14% +$86.9K 0.01% 604
2023
Q3
$513K Hold
17,400
﹤0.01% 1041
2023
Q2
$568K Buy
17,400
+4,800
+38% +$178K ﹤0.01% 1000
2023
Q1
$443K Hold
12,600
﹤0.01% 1059
2022
Q4
$577K Buy
12,600
+800
+7% +$34.4K ﹤0.01% 883
2022
Q3
$572K Hold
11,800
﹤0.01% 884
2022
Q2
$464K Hold
11,800
﹤0.01% 1069
2022
Q1
$434K Sell
11,800
-4,700
-28% -$167K ﹤0.01% 1304
2021
Q4
$752K Hold
16,500
﹤0.01% 1070
2021
Q3
$590K Hold
16,500
﹤0.01% 1243
2021
Q2
$327K Buy
16,500
+1,100
+7% +$25.8K ﹤0.01% 1607
2021
Q1
$358K Hold
15,400
﹤0.01% 1369
2020
Q4
$320K Buy
+15,400
New +$281K ﹤0.01% 1373

Other funds holding CYTK